Pulmonary

Apr 2, 2002

Simplified Practical Chart of Pulmonary
Vascular Segmental Anatomy.

Cote rendition of a practical pulmonary segmental chart to be used for the interpretation of V/Q lung scans.

[Table of Content]

A 74-year-old patient with metastatic prostate cancer with a positive left iliac wing lesion (SUVmax of 35.02) seen on (A) Zr-89 DFO-YS5 PET maximum projection image (MIP) and (B) PET/CT (red arrows). The lesion was graded 5 on PET but was not visible on CT (D) or (D) technitium-99 MDP bone scan.

New immuno-PET tracer shows promise in prostate cancer

June 15, 2026

Advancing molecular imaging together

Advancing molecular imaging together

May 24, 2026

SNMMI ShowCast Roundup

June 5, 2026

Lab Equipment Drug Manufacturing

Radiopharmaceutical manufacturers report uneven FDA inspections

June 4, 2026

New immuno-PET tracer shows promise in prostate cancer

Compared to conventional imaging, Zr-89 DFO-YS5 PET identified additional lesions.

June 15, 2026

A 74-year-old patient with metastatic prostate cancer with a positive left iliac wing lesion (SUVmax of 35.02) seen on (A) Zr-89 DFO-YS5 PET maximum projection image (MIP) and (B) PET/CT (red arrows). The lesion was graded 5 on PET but was not visible on CT (D) or (D) technitium-99 MDP bone scan.

What side effects do patients report after Pluvicto therapy?

Fatigue, pain flare, nausea, and urinary symptoms are among the most commonly reported immediate side effects of Pluvicto therapy.

June 5, 2026

Post-Pluvicto SPECT/CT with axial fused images of sacrum and sagittal maximum intensity projection of one of the patients who complained of increasing pain in the sacral region (arrows) post therapy.

SNMMI ShowCast Roundup

Science was the star in Los Angeles at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 5, 2026

Radiopharmaceutical manufacturers report uneven FDA inspections

RMTA lays out radiopharmaceutical regulatory and payment policy issues.

June 4, 2026

Lab Equipment Drug Manufacturing

Alpha Tau, Tolmar strike $196M deal to commercialize Alpha DaRT

By AuntMinnie.com staff writers

Tolmar will make a $20 million equity investment in Alpha Tau at closing and contribute $15 million toward construction of a new U.S. production facility.

June 3, 2026

SNMMI awards Martin Pomper 2026 Benedict Cassen Prize

By AuntMinnie.com staff writers

The SNMMI has awarded Martin Pomper, MD, PhD, the Benedict Cassen Prize for his contributions toward nuclear medicine research.

June 1, 2026

Martin Pomper, MD, PhD

ASCO: Lu-177 edotreotide yields sustained quality-of-life gains

By Erik L. Ridley

A poster presentation at ASCO 2026 highlighted quantifiable benefits for patients receiving the radiopharmaceutical treatment for GEP-NETs.

May 31, 2026

Archeus doses first patient in phase I RPT trial

By AuntMinnie.com staff writers

In preclinical work, Y-90 ARC-706 demonstrated tumor-selective uptake across multiple ICI-treated cancers.

May 27, 2026

Mevion to install first proton therapy system in Vietnam

By AuntMinnie.com staff writers

Mevion Medical Systems has signed an agreement to install what the firm says will be the first proton therapy system in Vietnam.

May 26, 2026

Business Handshake 400 (1)

Radnostix reports 27% revenue decline in Q1

By AuntMinnie.com staff writers

Radnostix reported a 27% decrease in the first quarter of 2026 compared to the previous year's first quarter.

May 21, 2026

Research Money 400

Niowave breaks ground on $75M Mich. Ac-225 production facility

By AuntMinnie.com staff writers

Niowave has broken ground on its Ac-225 production facility in Lansing, MI, with construction expected to be finished by 2028.

May 21, 2026

Construction Pharmaceutical Manufacturing 400

NRC to ease burden on radiopharmaceutical licensees

By AuntMinnie.com staff writers

The rule would eliminates decommissioning financial assurance (DFA) for all radionuclides with half-lives of 120 days or less.

May 19, 2026

Page 1 of 443